PlainRecalls
FDA Drug Moderate Class II Ongoing

INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01

Reported: February 4, 2026 Initiated: December 19, 2025 #D-0298-2026

Product Description

INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01

Reason for Recall

Failed Disintegration Specifications: above the time expected.

Details

Units Affected
3,640 bottles
Distribution
CA and HI
Location
Tokyo, N/A

Frequently Asked Questions

What product was recalled?
INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01. Recalled by Sato Pharmaceutical Co., Ltd. Units affected: 3,640 bottles.
Why was this product recalled?
Failed Disintegration Specifications: above the time expected.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 4, 2026. Severity: Moderate. Recall number: D-0298-2026.